GPCR Modulation in Breast Cancer
Breast cancer is the most prevalent cancer found in women living in developed countries. Endocrine therapy is the mainstay of treatment for hormone-responsive breast tumors (about 70% of all breast cancers) and implies the use of selective estrogen receptor modulators and aromatase inhibitors. In co...
Saved in:
Published in | International journal of molecular sciences Vol. 19; no. 12; p. 3840 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
02.12.2018
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!